MycoBiomDB – Record Details (MyCo_1681)

Biomarker Record Details

Database ID: MyCo_1681
DB IDMyCo_1681
TitleDiagnostic markers of allergic bronchopulmonary aspergillosis in patients with severe asthma
Year2020
PMID32246509
Fungal Diseases involvedAllergic bronchopulmonary aspergillosis
Associated Medical ConditionCystic fibrosis
GenusAspergillus
Speciesspp.
OrganismAspergillus spp.
Ethical StatementThe study protocol was approved by the Ethics Review Committee, informed consents were obtained from all the patients.
Site of InfectionLungs
Opportunistic invasiveOpportunistic
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameIL-8
Biomarker Full NameInterleukin-8
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationRussia
CohortProspective study included 21 patients with ABPA, 25 patients with severe asthma with fungal sensitization (SAFS), 37 patients with severe asthma without fungal sensitization (SAwFS), and 16 healthy people.
Cohort No.None
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismAllergic bronchopulmonary aspergillosis (ABPA) is a lung disease in patients with asthma or cystic fibrosis (CF) caused by chronic allergic inflammation to Aspergillus spp. antigens. The role of different immunological mediators in the formation of chronic allergic inflammation in patients with ABPA is not sufficiently explored.
TechniqueELISA
Analysis MethodELISA Based
ELISA kitsELISA Huma Reader HS by ELISA Kit (R&D Systems, Abingdon, UK), ELISA Kit (VEKTOR BEST, Novosibirsk, RF)
Assay DataNone
Validation Techniques usedELISA, CT
Up Regulation Down RegulationIncrease
Sequence DataNone
External LinkNone